SCHEMBL14488302

SCHEMBL14488302

Cc1ccc(-c2nsc(N3CCN(Cc4ccccc4C)CC3)n2)cn1.Cc1ccccc1CN1CCN(c2nc(-c3cncc(Cl)c3)ns2)CC1.FC(F)(F)c1ccc(CCN2CCN(c3nc(-c4cncc(Cl)c4)ns3)CC2)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR2 P34972 1/20 0.39
CYP3A4 P08684 1/20 0.37
ADRA1D P25100 1/20 0.35
ADRA1A P35348 1/20 0.35
ADRA1B P35368 1/20 0.35
MEN1 O00255 1/20 0.34
NPC1 O15118 1/20 0.34
RAB9A P51151 1/20 0.34
KMT2A Q03164 1/20 0.34
KDM4E B2RXH2 1/20 0.34
LMNA P02545 1/20 0.34
PHGDH O43175 1/20 0.34
CYP2C9 P11712 1/20 0.33
P2RX7 Q99572 1/20 0.32
CDK1 P06493 1/20 0.32
KDR P35968 1/20 0.32
SIGMAR1 Q99720 2/20 0.32
TMEM97 Q5BJF2 1/20 0.32
FABP6 P51161 1/20 0.32
ACHE P22303 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14488318 0.89 KMT2A (0.43) CNR2MEN1NPC1RAB9AKMT2A
SCHEMBL14486771 0.85 CNR2 (0.45) CNR2CYP3A4ADRA1DADRA1AADRA1B
SCHEMBL14486416 0.82 KMT2A (0.48) CNR2MEN1NPC1RAB9AKMT2A
SCHEMBL14486435 0.80 KMT2A (0.51) MEN1NPC1RAB9AKMT2AKDM4E
SCHEMBL14486640 0.78 FAAH (0.42) ADRA1DADRA1AADRA1BCYP2C9SIGMAR1
SCHEMBL14488343 0.78 MEN1 (0.36) ADRA1DADRA1AADRA1BMEN1NPC1
SCHEMBL14486569 0.78 HTR1A (0.46) CNR2CYP3A4KDM4ESIGMAR1
SCHEMBL14488459 0.78 PRKAA2 (0.35) ADRA1DADRA1AADRA1BMEN1NPC1
SCHEMBL14486386 0.77 SIGMAR1 (0.46) CNR2SIGMAR1
SCHEMBL14486671 0.76 FAAH (0.43) CNR2ADRA1DADRA1AADRA1BNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2726470-A1 1, 2, 4 -THIADIAZOL- 5 -YLPIPERAZINE DERIVATIVES USEFUL IN THE TREATMENT NEURODEGENERATIVE DISEASES reMynd NV (BE) 2014-05-07 EP claimed
WO-2013004642-A1 1, 2, 4 -THIADIAZOL- 5 -YLPIPERAZINE DERIVATIVES USEFUL IN THE TREATMENT NEURODEGENERATIVE DISEASES REMYND NV (BE) 2013-01-10 WO claimed
EP-2726470-A1 1, 2, 4 -THIADIAZOL- 5 -YLPIPERAZINE DERIVATIVES USEFUL IN THE TREATMENT NEURODEGENERATIVE DISEASES reMynd NV (BE) 2014-05-07 EP disclosed
WO-2013004642-A1 1, 2, 4 -THIADIAZOL- 5 -YLPIPERAZINE DERIVATIVES USEFUL IN THE TREATMENT NEURODEGENERATIVE DISEASES REMYND NV (BE) 2013-01-10 WO disclosed